FDA Opens Public Comment Period on Generative AI Medical Device Framework
The U.S. Food and Drug Administration (FDA) has taken a significant step toward formalizing oversight of generative AI (GenAI) in medical devices by publishing a draft framework and opening a public comment period.
The framework addresses a growing category of software-based medical tools that use generative AI to perform